496 related articles for article (PubMed ID: 23706827)
21. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
22. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
Karpati F; Jonasson J
Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
[TBL] [Abstract][Full Text] [Related]
23. Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients.
Yau YC; Ratjen F; Tullis E; Wilcox P; Freitag A; Chilvers M; Grasemann H; Zlosnik J; Speert D; Corey M; Stanojevic S; Matukas L; Leahy TR; Shih S; Waters V
J Cyst Fibros; 2015 Mar; 14(2):262-6. PubMed ID: 25453872
[TBL] [Abstract][Full Text] [Related]
24. Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.
Daniels TW; Rogers GB; Stressmann FA; van der Gast CJ; Bruce KD; Jones GR; Connett GJ; Legg JP; Carroll MP
J Cyst Fibros; 2013 Jan; 12(1):22-8. PubMed ID: 22717533
[TBL] [Abstract][Full Text] [Related]
25. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients.
Kolak M; Karpati F; Monstein HJ; Jonasson J
Int J Med Microbiol; 2003 Aug; 293(4):309-17. PubMed ID: 14503795
[TBL] [Abstract][Full Text] [Related]
26. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Stressmann FA; Rogers GB; Marsh P; Lilley AK; Daniels TW; Carroll MP; Hoffman LR; Jones G; Allen CE; Patel N; Forbes B; Tuck A; Bruce KD
J Cyst Fibros; 2011 Sep; 10(5):357-65. PubMed ID: 21664196
[TBL] [Abstract][Full Text] [Related]
27. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
Béghin L; Michaud L; Loeuille GA; Wizla-Derambure N; Sayah H; Sardet A; Thumerelle C; Deschildre A; Turck D; Gottrand F
Pediatr Pulmonol; 2009 May; 44(5):464-71. PubMed ID: 19360849
[TBL] [Abstract][Full Text] [Related]
28. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
[TBL] [Abstract][Full Text] [Related]
29. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
[TBL] [Abstract][Full Text] [Related]
30. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Moriarty TF; McElnay JC; Elborn JS; Tunney MM
Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
[TBL] [Abstract][Full Text] [Related]
31. Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients.
Fothergill JL; Ledson MJ; Walshaw MJ; McNamara PS; Southern KW; Winstanley C
J Cyst Fibros; 2013 Dec; 12(6):675-81. PubMed ID: 23726365
[TBL] [Abstract][Full Text] [Related]
32. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.
Tingpej P; Elkins M; Rose B; Hu H; Moriarty C; Manos J; Barras B; Bye P; Harbour C
Respirology; 2010 Aug; 15(6):923-9. PubMed ID: 20573059
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology and management of pulmonary infections in cystic fibrosis.
Gibson RL; Burns JL; Ramsey BW
Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
[TBL] [Abstract][Full Text] [Related]
34. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa.
Aaron SD; Ramotar K; Ferris W; Vandemheen K; Saginur R; Tullis E; Haase D; Kottachchi D; St Denis M; Chan F
Am J Respir Crit Care Med; 2004 Apr; 169(7):811-5. PubMed ID: 14670805
[TBL] [Abstract][Full Text] [Related]
35. Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Mirakhur A; Gallagher MJ; Ledson MJ; Hart CA; Walshaw MJ
J Cyst Fibros; 2003 Mar; 2(1):19-24. PubMed ID: 15463841
[TBL] [Abstract][Full Text] [Related]
36. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
Gillham MI; Sundaram S; Laughton CR; Haworth CS; Bilton D; Foweraker JE
J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
[TBL] [Abstract][Full Text] [Related]
37. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
38. The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysis.
Ramsay KA; Sandhu H; Geake JB; Ballard E; O'Rourke P; Wainwright CE; Reid DW; Kidd TJ; Bell SC
J Cyst Fibros; 2017 Jan; 16(1):70-77. PubMed ID: 27515017
[TBL] [Abstract][Full Text] [Related]
39. Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).
Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson RL; McKevitt M; Montgomery AB
J Antimicrob Chemother; 2011 Oct; 66(10):2398-404. PubMed ID: 21784781
[TBL] [Abstract][Full Text] [Related]
40. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
Ferroni A; Guillemot D; Moumile K; Bernede C; Le Bourgeois M; Waernessyckle S; Descamps P; Sermet-Gaudelus I; Lenoir G; Berche P; Taddei F
Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
